JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells

Journal of Biomedical Science

Volumn 13, Issue 3, 2006, Pages 357-371

  Huang, Shu ^a   Shen, Qun ^a,b   Mao, Wen Ge ^a   Li, Ai Ping ^a   Ye, Jian ^a   Liu, Qi Zhan ^a   Zou, Chang Ping ^c   Zhou, Jian Wei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Province Hospital of Traditional Chinese Medicine   (China)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

ATRA; Differentiation; HL 60 cells; JWA; RNA interference

Indexed keywords

ARSENIC TRIOXIDE; GENE PRODUCT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN JWA; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; JWA GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRACHEA MUCOSA; UPREGULATION;

CELL DIFFERENTIATION; CELL SURVIVAL; DOWN-REGULATION; GENES, REPORTER; HEAT-SHOCK PROTEINS; HL-60 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROMOTER REGIONS (GENETICS); RNA INTERFERENCE; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRETINOIN; UP-REGULATION;

EID: 33646561869     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9068-0     Document Type: Article

References (49)

1. Zauli G., Visani G., Bassini A., Caramelli E., Ottaviani E., Bertolaso L., Bertagnolo V., Borgatti P. and Capitani S., Nuclear translocation of protein kinase C-alpha and -zeta isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid. Br. J. Haematol. 93: 542-550, 1996.
2. Tallman M.S., Nabhan C., Feusner J.H. and Rowe J.M., Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99: 759-767, 2002.
3. Idres N., Benoit G., Flexor M.A., Lanotte M. and Chabot G.G., Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Cancer Res. 6: 700-705, 2001.
4. Launay S., Gianni M., Diomede L., Machesky L.M., Enouf J. and Papp B., Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR α and calcium-dependent signaling. Blood 101: 3220-3228, 2003.
5. Chambon P., A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954, 1996.
6. Zhou J.W., Di Y.P. and Zhao Y.H. A novel cytoskeleton associate gene-cloning, identification, sequencing, regulation of expression and tissue distribution of JWA. In: Ye X.S., Shen B.F. and Tang X.F. (Eds), Investigation on Cell Modulation: Signal Transduction, Apoptosis and Gene Expression. Beijing, 1999, pp. 110-119.
7. Lin C.I., Orlov I., Ruggiero A.M., Dykes-Hoberg M., Lee A., Jackson M. and Rothstein J.D., Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410: 84-88, 2001.
8. Butchbach M.E., Lai L. and Lin C.L., Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene 292: 81-90, 2002.
9. Butchbach M.E., Guo H. and Lin C.L., Methyl-beta-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. J. Neurochem. 84: 891-894, 2003.
10. Schweneker M., Bachmann A.S. and Moelling K., JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett. 579: 1751-1758, 2005.
11. Ingley E., Williams J.H., Walker C.E., Tsai S., Colley S., Sayer M.S., Tilbrook P.A., Sarna M., Beaumont J.G. and Klinken S.P., A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61-beta subunit. FEBS Lett. 459: 69-74, 1999.
12. Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O., Nagano Y., Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H. and Sugano S., Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318, 2003.
13. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J. and Der C.J., Increasing complexity of Ras signaling. Oncogene 17: 1395-1413, 1998.
14. Bar-Sagi D. and Hall A., Ras and Rho GTPases: a family reunion. Cell 103: 227-238, 2000.
15. Kyriakis J.M. and Avruch J., Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81: 807-869, 2001.
16. Shen Q., Zhou J.W., Shen R.L., Lu H., Cao H.X. and Xia W., The significance of expression of JWA gene in acute non-lymphocytic leukemia. Acta Nanjing Med. Univ. 21: 406-407, 2001(in Chinese).
17. Shen Q., Zhou J.W., Shen R.L., Lu H., Cao H.X. and Xia W., To detect the expression of JWA gene by semi-quantity RT-PCR in chronic myelogenous leukemia. Jiangsu Med. J. 27: 1-3, 2001(in Chinese).
18. Xia W., Zhou J.W. and Cao H.X., The relationship between structure and function of JWA in the modulation of cell differentiation. Chinese Sci. Bull. 46: 2063-2067, 2001.
19. Cao H.X., Xia W. and Zhou J.W., The role of JWA in acute promyelocytic leukemia cell differentiation and apoptosis triggered by retinoic acid, 12-tetradecanoylphorbol-13-acetate and arsenic trioxide. Chinese Sci. Bull. 47: 834-838, 2002.
20. Savickiene J., Gineitis A. and Stigbrand T., Modulation of apoptosis of proliferating and differentiating HL-60 cells by protein kinase inhibitors: suppression of PKC or PKA differently affects cell differentiation and apoptosis. Cell Death Differ 6: 698-709, 1999.
21. Paquette R.L. and Koeffler H.P., Differentiation therapy. Hematol. Oncol. Clin. N. Am. 6: 687-706, 1992.
22. Scott R.E., The differentiation therapy of cancer: past, present, and future. Mol. Cell Differ 3: 157-173, 1995.
23. Chou T.C. and Talalay P., Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27-55, 1984.
24. Berenbaum M.C., Criteria for analyzing interactions between biologically active agents. Cancer Res. 35: 269-335, 1981.
25. Fontana J.A., Reppucci A., Durham J.P. and Miranda D., Correlation between the induction of leukemic cell differentiation by various retinoids and modulation of protein kinases. Cancer Res. 46: 2468-2473, 1986.
26. Carter C.A., Parham G.P. and Chambers T., Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-alpha. Pathobiology 66: 284-292, 1998.
27. Newton A.C., Regulation of protein kinase C. Curr. Opin. Cell Biol. 9: 161-167, 1997.
28. Yang K.D., Mizobuchi T., Kharbanda S.M., Datta R., Huberman E., Kufe D.W. and Stone R.M., All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line. Blood 83: 490-496, 1994.
29. Bertolaso L., Gibellini D., Secchiero P., Previati M., Falgione D., Visani G., Rizzoli R., Capitani S. and Zauli G., Accumulation of catalytically active PKC-zeta into the nucleus of HL-60 cell line plays a key role in the induction of granulocytic differentiation mediated by all-trans retinoic acid. Br. J. Haematol. 100: 541-549, 1998.
30. Kikkawa U., Takai Y., Tanaka Y., Miyake R. and Nishizuka Y., Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258: 11442-11445, 1983.
31. 3) in the treatment of acute promyelocytic leukemia (APL):∥. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360, 1997.
32. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P. and Warrell R.P. Jr., Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339: 1341-1348, 1998.
33. Hannon G.J., RNA interference. Nature 418: 244-251, 2002.
34. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K. and Tuschl T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
35. Castanotto D., Li H. and Rossi J.J., Functional siRNA expression from transfected PCR products. RNA 8: 1454-1460, 2002.
36. Gou D., Jin N. and Liu L., Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett. 548: 113-118, 2003.
37. Zheng L., Liu J., Batalov S., Zhou D., Orth A., Ding S. and Schultz P.G., An approach to genome wide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 101: 135-140, 2004.
38. Valverde M.A. and Parker M.G., Classical and novel steroid actions: a unified but complex view. Trends Biochem. Sci. 27: 172-173, 2002.
39. Liu T.X., Zhang J.W., Tao J., Zhang R.B., Zhang Q.H., Zhao C.J., Tong J.H., Lanotte M., Waxman S., Chen S.J., Mao M., Hu G.X., Zhu L. and Chen Z., Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 96: 1496-1504, 2000.
40. Radominska-Pandya A., Chen G., Czernik P.J., Little J.M., Samokyszyn V.M., Carter C.A. and Nowak G., Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). J. Biol. Chem. 275: 22324-22330, 2000.
41. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G. and Waxman S., Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94: 2102-2111, 1999.
42. Cai X., Shen Y.L., Zhu Q., Jia P.M., Yu Y., Zhou L., Huang Y., Zhang J.W., Xiong S.M., Chen S.J., Wang Z.Y., Chen Z. and Chen G.Q., Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14: 262-270, 2000.
43. Jing Y., Wang L., Xia L., Chen G.Q., Chen Z., Miller W.H. and Waxman S., Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97: 264-269, 2001.
44. Andre C., Guillemin M.C. and Zhu J., The PML and PML/ RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp. Cell Res. 229: 253-260, 1996.
45. Leid M.P., Kastner R. and Lyons H., Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395, 1992.
46. Kliewer S.A., Umesono K., Mangelsdorf D.J. and Evans R.M., Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446-449, 1992.
47. Gery S., Park D.J., Vuong P.T., Chili D.Y., Lemp N. and Koeffler H.P., Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes. Blood 104: 3911-3917, 2004.
48. Tenen D.G., Hromas R., Licht J.D. and Zhang D.E., Transcription factors, normal myeloid development, and leukemia. Blood 90: 489-519, 1997.
49. Ubeda M., Wang X.Z., Zinszner H., Wu I., Habener J.F. and Ron D., Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol. Cell Biol. 16: 1479-1489, 1996.